Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marbach

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
European Journal of Nuclear Medicine|April 13, 1999
Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1- Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogueF Rösch, H Herzog, B Stolz, et al.
Obstetrics and Gynecology|November 1, 1975
Pituitary and ovarian response patterns to stimulation in the postpartum and in galactorrhea-amenorrhea. The role of prolactinE del Pozo, L Varga, K D Schulz, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1986
Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatinJ Pless, W Bauer, U Briner, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 15, 2001
Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiatorE V Dimaraki, C A Jaffe, R Demott-Friberg, et al.
Acta Endocrinologica|April 1, 1986
Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administrationE del Pozo, M Neufeld, K Schlüter, et al.
Life Sciences|January 1, 1991
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validationW H Bakker, R Albert, C Bruns, et al.
Metabolism: Clinical and Experimental|August 1, 1996
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patientsI Lancranjan, C Bruns, P Grass, et al.
Life Sciences|January 1, 1991
In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in ratsW H Bakker, E P Krenning, J C Reubi, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
European Journal of Nuclear Medicine|April 13, 1999
Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1- Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogueF Rösch, H Herzog, B Stolz, et al.
Obstetrics and Gynecology|November 1, 1975
Pituitary and ovarian response patterns to stimulation in the postpartum and in galactorrhea-amenorrhea. The role of prolactinE del Pozo, L Varga, K D Schulz, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1986
Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatinJ Pless, W Bauer, U Briner, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 15, 2001
Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiatorE V Dimaraki, C A Jaffe, R Demott-Friberg, et al.
Acta Endocrinologica|April 1, 1986
Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administrationE del Pozo, M Neufeld, K Schlüter, et al.
Life Sciences|January 1, 1991
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validationW H Bakker, R Albert, C Bruns, et al.
Metabolism: Clinical and Experimental|August 1, 1996
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patientsI Lancranjan, C Bruns, P Grass, et al.
Life Sciences|January 1, 1991
In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in ratsW H Bakker, E P Krenning, J C Reubi, et al.
Pageof 4